Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Leaky Scanning02:28

Leaky Scanning

During most eukaryotic translation processes, the small 40S ribosome subunit scans an mRNA from its 5' end until it encounters the first start AUG codon. The large 60S ribosomal subunit then joins the smaller one to initiate protein synthesis. The location of the translation initiation is largely determined by the nucleotides near the start codon as there may be multiple translation initiation sites present on the mRNA.  Marilyn Kozak discovered that the sequence RCCAUGG (where R stands for...
Influenza01:27

Influenza

Influenza is an acute, highly communicable viral disease that affects the respiratory tract and is responsible for seasonal epidemics worldwide. Influenza A is the most prevalent type associated with widespread outbreaks and is subtyped based on two surface glycoproteins: hemagglutinin (H) and neuraminidase (N), as in H1N1. These glycoproteins are essential for viral infectivity, transmission, and immune recognition. Transmission occurs primarily through respiratory droplets and contaminated...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

SARS-CoV-2 Omicron BA.2.86 and JN.1 expand tropism in human proximal intestinal epithelium.

Nature communications·2026
Same author

Population immunity, post-vaccine and post-infection antibody responses to influenza A (H3N2) subclade J.2 and K (J.2.4.1) viruses, Hong Kong, 2025.

Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin·2026
Same author

SARS-CoV-2 antibody responses in children exhibit higher FcR engagement and avidity than in adults.

Nature communications·2025
Same author

The impact of clade B lineage 5 MERS coronaviruses spike mutations from 2015 to 2023 on virus entry and replication competence.

bioRxiv : the preprint server for biology·2025
Same author

Detection and characterisation of high pathogenicity avian influenza virus (H5N1/H5N8) clade 2.3.4.4b, Hong Kong SAR, China, 2021 to 2024.

Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin·2025
Same author

Mutation nsp6 L232F associated with MERS-CoV zoonotic transmission confers higher viral replication in human respiratory tract cultures ex-vivo.

bioRxiv : the preprint server for biology·2023

Related Experiment Video

Updated: Jun 21, 2026

Quantitative Analyses of all Influenza Type A Viral Hemagglutinins and Neuraminidases using Universal Antibodies in Simple Slot Blot Assays
13:12

Quantitative Analyses of all Influenza Type A Viral Hemagglutinins and Neuraminidases using Universal Antibodies in Simple Slot Blot Assays

Published on: April 4, 2011

One step closer to universal influenza epitopes.

Olive Tw Li1, Leo Lm Poon

  • 1Department of Microbiology, The University of Hong Kong, Hong Kong SAR, China.

Expert Review of Anti-Infective Therapy
|August 18, 2009
PubMed
Summary

Scientists are reviewing developments in neutralizing antibodies that can broadly target multiple influenza A virus subtypes. This research is crucial for pandemic preparedness and developing new influenza therapies and vaccines.

Area of Science:

  • Virology
  • Immunology
  • Structural Biology

Background:

  • Influenza viruses continuously evolve through antigenic drift and shift, evading the human immune system.
  • Emerging H5N1 and novel H1N1 strains highlight the pandemic risk from animal influenza viruses.
  • Developing broadly reactive neutralizing antibodies is vital for influenza pandemic preparedness.

Purpose of the Study:

  • To review recent advancements in identifying and characterizing broadly neutralizing antibodies against influenza A viruses.
  • To explore the structural and functional basis of broad-spectrum neutralization for therapeutic and vaccine development.

Main Methods:

  • Review of scientific literature on influenza virus neutralization and antibody discovery.
  • Analysis of structural and functional data of antibodies targeting conserved influenza epitopes.

More Related Videos

Generation of Escape Variants of Neutralizing Influenza Virus Monoclonal Antibodies
07:55

Generation of Escape Variants of Neutralizing Influenza Virus Monoclonal Antibodies

Published on: August 29, 2017

Use of an Influenza Antigen Microarray to Measure the Breadth of Serum Antibodies Across Virus Subtypes
08:52

Use of an Influenza Antigen Microarray to Measure the Breadth of Serum Antibodies Across Virus Subtypes

Published on: July 26, 2019

Related Experiment Videos

Last Updated: Jun 21, 2026

Quantitative Analyses of all Influenza Type A Viral Hemagglutinins and Neuraminidases using Universal Antibodies in Simple Slot Blot Assays
13:12

Quantitative Analyses of all Influenza Type A Viral Hemagglutinins and Neuraminidases using Universal Antibodies in Simple Slot Blot Assays

Published on: April 4, 2011

Generation of Escape Variants of Neutralizing Influenza Virus Monoclonal Antibodies
07:55

Generation of Escape Variants of Neutralizing Influenza Virus Monoclonal Antibodies

Published on: August 29, 2017

Use of an Influenza Antigen Microarray to Measure the Breadth of Serum Antibodies Across Virus Subtypes
08:52

Use of an Influenza Antigen Microarray to Measure the Breadth of Serum Antibodies Across Virus Subtypes

Published on: July 26, 2019

Main Results:

  • Identification of neutralizing antibodies capable of targeting multiple influenza A subtypes (avian and human).
  • Understanding the structural mechanisms underlying broad-spectrum antibody recognition of conserved viral regions.

Conclusions:

  • Broadly neutralizing antibodies represent a promising strategy for influenza pandemic preparedness.
  • Further research into these antibodies can lead to novel therapeutic interventions and vaccine designs.